Railway Pension Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-31,700
Closed -$4.87M 221
2023
Q1
$4.87M Sell
31,700
-12,200
-28% -$2.01M 0.05% 186
2022
Q4
$7.89M Hold
43,900
0.08% 166
2022
Q3
$5.19M Hold
43,900
0.06% 184
2022
Q2
$6.27M Buy
+43,900
New +$6.27M 0.06% 174
2021
Q4
Sell
-15,900
Closed -$6.12M 247
2021
Q3
$6.12M Buy
+15,900
New +$5.86M 0.05% 194
2020
Q3
Sell
-60,200
Closed -$3.87M 293
2020
Q2
$3.87M Buy
+60,200
New +$3.3M 0.04% 252

Other funds holding MRNA

Railway Pension Investments's MRNA Position: Q2 2023 in Review

Railway Pension Investments sold out of Moderna (MRNA) in Q2 2023, closing a stake of 31,700 shares — an estimated $4.87M sold.

Railway Pension Investments first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $7.89M in Q4 2022. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Railway Pension Investments reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Railway Pension Investments sold 31,700 Moderna shares in Q2 2023, an estimated $4.87M.
  • Railway Pension Investments first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • Railway Pension Investments's Moderna position peaked at $7.89M in Q4 2022.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Railway Pension Investments's 13F filing for Q2 2023, filed 11 Aug 2023.